adenovirus vector E2b-gag vaccine (E.C7 cell line) (Etubics/Duke Human Vaccine Institute)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameadenovirus vector E2b-gag vaccine (E.C7 cell line) (Etubics/Duke Human Vaccine Institute)
Drug Alias Nameadenovirus vector E2b-gag HIV vaccine (Etubics)
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEtubics Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDuke UniversityEtubics Corp
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A